WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the 5th Annual OneMedForum at the Sir Frances Drake Hotel, San Francisco, CA on January 9-12, 2012. Dr. Gozani intends to provide an update on the Company’s business activities and on its new product NC-stat® DPNCheckTM for testing of systemic neuropathies such as diabetic peripheral neuropathy (DPN).
